Kimelman & Baird LLC Buys New Shares in Procter & Gamble Company (The) $PG

Kimelman & Baird LLC bought a new position in shares of Procter & Gamble Company (The) (NYSE:PG) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 19,804 shares of the company’s stock, valued at approximately $2,904,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. BlackRock Inc. acquired a new stake in shares of Procter & Gamble in the second quarter worth approximately $27,862,105,000. State Street Corp raised its stake in Procter & Gamble by 1.0% during the fourth quarter. State Street Corp now owns 101,618,926 shares of the company’s stock worth $14,563,008,000 after purchasing an additional 984,102 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Procter & Gamble by 3.3% in the 4th quarter. Geode Capital Management LLC now owns 62,647,882 shares of the company’s stock valued at $8,962,689,000 after purchasing an additional 1,974,556 shares during the last quarter. Norges Bank purchased a new stake in shares of Procter & Gamble during the 4th quarter valued at $4,664,783,000. Finally, Price T Rowe Associates Inc. MD raised its position in shares of Procter & Gamble by 3.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 29,612,826 shares of the company’s stock worth $4,243,815,000 after buying an additional 1,091,091 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Price Performance

PG opened at $143.71 on Monday. The company has a market capitalization of $334.04 billion, a P/E ratio of 21.71, a PEG ratio of 4.43 and a beta of 0.39. The company has a 50-day moving average of $147.11 and a 200-day moving average of $148.21. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.47 and a current ratio of 0.68. Procter & Gamble Company has a 1-year low of $137.62 and a 1-year high of $167.25.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.02. The business had revenue of $21.20 billion during the quarter, compared to the consensus estimate of $21.38 billion. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%.The company’s revenue for the quarter was up 1.5% compared to the same quarter last year. During the same period last year, the firm earned $1.48 earnings per share. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. Equities analysts expect that Procter & Gamble Company will post 6.98 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, August 17th. Stockholders of record on Friday, July 24th were issued a $1.0885 dividend. This represents a $4.35 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date was Friday, July 24th. Procter & Gamble’s payout ratio is 65.71%.

Insider Activity at Procter & Gamble

In related news, insider Marc S. Pritchard sold 4,030 shares of the firm’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $143.79, for a total transaction of $579,473.70. Following the transaction, the insider directly owned 187,001 shares in the company, valued at $26,888,873.79. This trade represents a 2.11% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Matthew W. Janzaruk sold 359 shares of Procter & Gamble stock in a transaction on Monday, August 24th. The stock was sold at an average price of $145.24, for a total transaction of $52,141.16. Following the completion of the transaction, the chief accounting officer directly owned 1,271 shares of the company’s stock, valued at approximately $184,600.04. This represents a 22.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 6,627 shares of company stock valued at $953,417. Corporate insiders own 0.20% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the company. Argus downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a report on Friday, August 7th. JPMorgan Chase & Co. reduced their target price on shares of Procter & Gamble from $164.00 to $162.00 and set an “overweight” rating on the stock in a report on Thursday, July 16th. Royal Bank Of Canada reissued an “outperform” rating on shares of Procter & Gamble in a research report on Wednesday, August 19th. Sanford C. Bernstein reiterated a “market perform” rating and issued a $149.00 target price on shares of Procter & Gamble in a research note on Monday, August 24th. Finally, HSBC restated a “hold” rating and issued a $149.00 price target (down from $182.00) on shares of Procter & Gamble in a report on Thursday, July 30th. Thirteen investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $161.19.

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.